🧾 Journal Overview Title: Neurology and Therapy
Publisher: Springer Healthcare
ISSN: 2193-8231 (print) / 2193-6549 (online)
Established: 2012
Access Type: Open Access
Indexing: PubMed, Scopus, DOAJ, Embase, Google Scholar
Publication Model: Continuous publication (online only)
🧠 Scope and Aims Neurology and Therapy focuses on clinical research, therapeutic interventions, and real-world studies in neurology. It aims to provide a platform for both original research and practical insights on the management of neurological disorders.
Core topics include: Multiple sclerosis
Alzheimer’s disease and dementias
Parkinson’s disease
Stroke
Epilepsy
Neuropathic pain
Sleep disorders
Neurocritical care
Migraine
Pharmacological and device-based therapies
✅ Strengths Therapeutic focus: Unlike broader neurology journals, it emphasizes clinical applicability and treatment strategies, which appeals to neurologists and clinicians looking for real-world relevance.
Open access: All articles are freely available, improving visibility and dissemination.
Rapid publication: Known for relatively short peer-review and publication cycles, which supports timely dissemination of data.
Multiformat content: Includes video abstracts, infographics, and plain language summaries, which enhance accessibility and patient-centered communication.
Patient voice inclusion: Occasionally includes patient perspectives, aligning with current trends in participatory medicine.
⚠️ Limitations Lack of methodological rigor in some studies: The journal publishes many real-world studies and case series with limited internal validity (small sample sizes, lack of controls, retrospective designs).
Not among top-tier neurology journals: It is not considered a leading journal in terms of impact factor, prestige, or citation metrics. Its primary niche is practical, not groundbreaking science.
Sponsored content: Some articles are industry-supported or written in collaboration with pharma, requiring the reader to critically assess for bias despite declarations of conflicts of interest.
Limited basic science: The journal does not cater to experimental neuroscience or mechanistic studies, making it less attractive to translational researchers.
🩺 Clinical Usefulness Neurology and Therapy is a useful source for up-to-date therapeutic approaches, especially in common neurological diseases where pharmacologic management evolves rapidly. It serves clinicians who value real-world data and pragmatic approaches over purely theoretical or experimental content.
However, for systematic reviews, meta-analyses, or guideline-setting research, readers should supplement it with higher-impact journals (e.g., Neurology, Lancet Neurology, Brain).
📊 Ideal Audience General neurologists
Pain specialists
Clinicians seeking updates in pharmacotherapy
Health policy and pharma professionals
Residents and trainees exploring applied therapeutics
🧭 Final Verdict Practical and accessible but methodologically modest. Use it as a source for therapeutic trends and practical updates—not as a substitute for high-impact evidence.